Nivolumab
CA209-8FC
Phase 1 small_molecule completed
Quick answer
Nivolumab for Melanoma is a Phase 1 program (small_molecule) at Bristol-Myers Squibb with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bristol-Myers Squibb
- Indication
- Melanoma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed